Otenabant

Structural formula
General
Non-proprietary name	Otenabant
other names	CP-945,598
Molecular formula	C 25 H 25 Cl 2 N 7 O 1
External identifiers / databases
PubChem	10052040
ChemSpider	8227602
DrugBank	DB11745
Wikidata	Q7108517
Drug information
ATC code	A08 AX
Drug class	Anorectics
Mechanism of action	Selective cannabinoid receptor - CB 1 - antagonist
properties
Molar mass	510.4 g · mol -1
safety instructions
	Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS hazard labeling ; no classification available
	As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Otenabant is a drug that should be used as a drug for obesity . However, the pharmaceutical company Pfizer withdrew its approval when problems, in the form of psychiatric side effects, with the structurally similar rimonabant became apparent.

Like rimonabant, Otenabant is a CB ₁ receptor antagonist.

Individual evidence

↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
↑ M. Kim: Design, chemical synthesis, and biological evaluation of novel triazolyl analogues of taranabant (MK-0364), a cannabinoid-1 receptor inverse agonist. In: Tetrahedron. Volume 64, number 48, 2008, pp. 10802-10809, doi : 10.1016 / j.tet.2008.09.057 .

[NV-1] This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.

[Kim_2008-2] M. Kim: Design, chemical synthesis, and biological evaluation of novel triazolyl analogues of taranabant (MK-0364), a cannabinoid-1 receptor inverse agonist. In: Tetrahedron. Volume 64, number 48, 2008, pp. 10802-10809, doi : 10.1016 / j.tet.2008.09.057 .